ALL
Clinical trials for ALL explained in plain language.
Never miss a new study
Get alerted when new ALL trials appear
Sign up with your email to follow new studies for ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental antibody GNR-084 tested against Hard-to-Treat leukemia
Disease control Stopped earlyResearchers are testing an experimental antibody called GNR-084 in adults with B-cell acute lymphoblastic leukemia that has come back or stopped responding to treatment. The trial enrolls 14 people aged 18 to 45 who have already received at least two prior therapies. Participants…
Matched conditions: ALL
Phase 1/2 • Sponsor: AO GENERIUM • Aim: Disease control
Last updated Sep 21, 2026 13:00 UTC
-
Promising combo for tough blood cancers halted early — only 4 patients enrolled
Disease control Stopped earlyThis study tested whether adding rapamycin to high-dose chemotherapy could help people with aggressive blood cancers (like certain leukemias and lymphomas) that had returned or not responded to prior treatment. Only 4 adults aged 18–65 took part before the study was stopped early…
Matched conditions: ALL
Phase 1/2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC